TY  - BOOK
ED  - United States.
TI  - Bringing Low-Cost Options and Competition while Keeping Incentives for New Generics Act of 2019: report (to accompany H.R. 938) (including cost estimate of the Congressional Budget Office)
T2  - Report / 116th Congress, 1st session, House of Representatives
AV  - KF32 .E55 2019g
PY  - 2019///]
CY  - [Washington, D.C.]
PB  - [U.S. Government Publishing Office]
KW  - Pharmaceutical industry
KW  - United States
KW  - Quality control
KW  - Generic drugs
KW  - Standards
KW  - Effectiveness
KW  - Prices
KW  - Drugs
KW  - Cost effectiveness
KW  - Legislative materials
KW  - lcgft
N1  - "May 2, 2019."; CRDP Program record; Includes bibliographical references
UR  - https://purl.fdlp.gov/GPO/gpo122825
UR  - https://purl.fdlp.gov/GPO/gpo122826
ER  -